Satoshi Muto

5PUBLICATIONS

32CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jul 01, 2026

Clinical utility of comprehensive genomic profiling in thoracic malignancies beyond conventional gene testing.

|Dec 23, 2025

Perioperative Nivolumab in Resectable Non-Small Cell Lung Cancer: A Subanalysis of Japanese Patients From CheckMate 77T.

Fumihiro Tanaka, Yasutaka Watanabe, Shunichi Sugawara

|Nov 04, 2024

YAP Regulates HER3 Signaling-Driven Adaptive Resistance to RET Inhibitors in RET-Aberrant Cancers.

Yuki Katayama, Tadaaki Yamada, Keiko Tanimura

|Jan 21, 2023

Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers.

Satoshi Muto, Akio Enta, Yoshiyuki Maruya

|Oct 01, 2021

The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study.

Mitsuro Fukuhara, Satoshi Muto, Sho Inomata

Pageof 1

Frequent Collaborators

Yuki Katayama

Tadaaki Yamada

Keiko Tanimura

Hayato Kawachi

Masaki Ishida

Yohei Matsui

Soichi Hirai

Ryota Nakamura

Kenji Morimoto

Naoki Furuya

Frequent Collaborators

Yuki Katayama

Tadaaki Yamada

Keiko Tanimura

Hayato Kawachi